Neurodegenerative Diseases
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.0 | Q1 | 77.4% | 0.514 | Q3 | 61.9% |
| 2024 | 2.6 | Q2 | 52.3% | 0.852 | Q2 | 79.8% |
| 2023 | 1.9 | Q4 | 22.8% | 0.648 | Q2 | 73.3% |
| 2022 | 3.0 | Q3 | 38.7% | 0.695 | Q2 | 76.6% |
| 2021 | 3.4 | Q3 | 44.2% | 0.729 | Q2 | 78.6% |
| 2020 | — | — | 0.980 | Q2 | 84.9% | |
| 2019 | — | — | 1.010 | Q2 | 85.8% | |
| 2018 | — | — | 1.075 | Q2 | 85.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1660-2854
ISSN
1660-2862
region
Western Europe
coverage
2004-2025